PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.630
-0.010 (-0.61%)
At close: Mar 9, 2026, 4:00 PM EDT
1.622
-0.008 (-0.51%)
After-hours: Mar 9, 2026, 6:56 PM EDT
PMV Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 87 | 67 | 78 | 159 | 397 | 1,048 | |
| Market Cap Growth | 18.30% | -14.88% | -50.73% | -60.08% | -62.10% | -61.94% | |
| Enterprise Value | -25 | -62 | -107 | -67 | 151 | 733 | |
| Last Close Price | 1.63 | 1.25 | 1.51 | 3.10 | 8.70 | 23.10 | |
| PB Ratio | 0.83 | 0.64 | 0.44 | 0.70 | 1.62 | 3.40 | |
| P/TBV Ratio | 0.83 | 0.64 | 0.44 | 0.70 | 1.62 | 3.40 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.06 | 0.06 | 0.04 | |
| Net Debt / Equity Ratio | -1.07 | -1.07 | -1.03 | -0.95 | -0.93 | -0.98 | |
| Net Debt / EBITDA Ratio | 1.30 | 1.30 | 2.18 | 2.73 | 2.99 | 5.22 | |
| Net Debt / FCF Ratio | 1.52 | 1.52 | 3.51 | 3.80 | 3.20 | 6.32 | |
| Quick Ratio | 9.89 | 9.89 | 11.79 | 14.47 | 22.25 | 24.32 | |
| Current Ratio | 10.09 | 10.09 | 12.22 | 14.78 | 22.80 | 24.66 | |
| Return on Equity (ROE) | -55.37% | -55.37% | -29.23% | -29.24% | -26.44% | -17.33% | |
| Return on Assets (ROA) | -35.00% | -35.00% | -23.92% | -19.17% | -16.00% | -10.45% | |
| Return on Capital Employed (ROCE) | -82.00% | -82.00% | -48.00% | -33.70% | -29.70% | -18.30% | |
| Earnings Yield | -89.43% | -116.88% | -75.13% | -43.48% | -18.45% | -5.52% | |
| FCF Yield | -84.68% | -110.66% | -66.47% | -35.70% | -18.06% | -4.57% | |
| Buyback Yield / Dilution | -1.87% | -1.87% | -7.42% | -5.31% | -1.01% | -214.23% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.